[1]
|
Braunwald, E. (2008) Biomarkers in heart failure. New England Journal of Medicine, 358, 2148-2159.
doi:10.1056/NEJMra0800239
|
[2]
|
Goldsmith, E.C. and Borg, T.K. (2002) The dynamic interaction of the extra cellular matrix in cardiac remodeling. Journal Cardiac Failure, 8, 314-318.
doi:10.1054/jcaf.2002.129258
|
[3]
|
Cleutjens, P.M.J. and Creemers, E.E.J.M. (2002) Integration of concepts: Cardiac extracellular matrix remodelling after myocardial infarction. Journal Cardiac Failure, 8, 344-348. doi:10.1054/jcaf.2002.129261
|
[4]
|
Postiglione, L., Montagnani, S., Rossi, G., et al. (2006) Granulocyte macrophage-colony stimulating factor receptor expression on human cardiomyocytes from end-stage heart failure patients. Eurpean Journal of Heart Failure, 8, 564-570. 8, 564-570.
doi:10.1016/j.ejheart.2005.12.007
|
[5]
|
Beltrami, A.P., Urbanek, K., Anversa, P., et al. (2001) Evidence that human cardiac myocytes divide after myocardial infarction. New England Journal of Medicine, 344, 1750-1757. doi:10.1056/NEJM200106073442303
|
[6]
|
Beltrami, A.P., Barlucchi, L., Anversa, P., et al. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114, 763-776.
doi:10.1016/S0092-8674(03)00687-1
|
[7]
|
Nadal-Ginard, B., Kajstura, J., Leri, A. and Anversa, P. (2003) Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circulation Research, 92, 139-150. doi:10.1161/01.RES.0000053618.86362.DF
|
[8]
|
Urbanek, K., Quaini, F., Anversa, P., et al. (2003) Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proceedings of the National Academy of Sciences USA, 100, 10440-10445.
doi:10.1073/pnas.1832855100
|
[9]
|
Bendall, J.K., Heymes, T., Ratajczak, P. and Samuel, J.L. (2002) Extracellular matrix and cardiac remodelling. Cardiovascular Research, 95, 1226-1239.
|
[10]
|
Shamhart, P.E. and Meszaros, J.G. (2010) Non-fibrillar collagens: Key mediators of postinfarction cardiac remodeling? Journal Molecular Cell Cardiology 48, 530- 537. doi:10.1016/j.yjmcc.2009.06.017
|
[11]
|
Durbeej, M. (2010) Laminins. Cell Tissue Research, 339, 259-268. doi:10.1007/s00441-009-0838-2
|
[12]
|
Jones, J.C.R., Dehart, G.W., Gonzales, M. and Goldfinger, L.E. (2000) Laminins: An overview. Microsc Research Technique, 1, 211-213.
doi:10.1002/1097-0029(20001101)51:3<211::AID-JEMT1>3.0.CO;2-P
|
[13]
|
Ehrig, K., Leivo, I., Argraves, W.S., Ruoslahti, E. and Engvall, E. (1990) Merosin, a tissue-specific basement membrane protein, is a laminin-like protein. Proceedings of the National Academy of Sciences USA, 87, 3264-3268. doi:10.1073/pnas.87.9.3264
|
[14]
|
Campbell, K.P. (1995) Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage. Cell, 80, 675-679. doi:10.1016/0092-8674(95)90344-5
|
[15]
|
Di Somma, S., Marotta, M., de Divitiis, O., et al. (2000) Changes in myocardial cytoskeletal intermediate filaments and myocyte contractile dysfunction in dilatative cardiomyopathy: An in vivo study in humans. Heart, 84, 659-667. doi:10.1136/heart.84.6.659
|
[16]
|
Oliviero, P., Chassagne, C., Salichon, N., Corbier, A., et al. (2000) Expression of laminin α2-chain during normal and pathological growth of myocardium in rat and human. Cardiovascular Research, 46, 346-355.
doi:10.1016/S0008-6363(00)00034-1
|
[17]
|
Chiquet-Ehrismann, R. and Chiquet, M. (2003) Tenascins: Regulation and putative functions during pathological stress. Journal of Pathology, 200, 488-499.
doi:10.1002/path.1415
|
[18]
|
Imanaka-Yoshida, K., Hiroe, M., Yasutomi, Y. and Toyozaki, T., et al. (2002) Tenascin-C is a useful marker for disease activity in myocarditis. Journal of Pathology, 197, 388-394. doi:10.1002/path.1131
|
[19]
|
Ikuta, T., Ariga, H. and Matsumoto, K. (2000) Extracellular matrix Tenascin X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation. Genes Cells, 5, 913-927.
doi:10.1046/j.1365-2443.2000.00376.x
|
[20]
|
Ikuta, T., Ariga, H. and Matsumoto, K. (2001) Effect of Tenascin-X together with vascular endothelial growth factor A on cell proliferation in cultured embrionic hearts. Biological Pharmaceutical Bulletin, 24, 1320-1323.
doi:10.1248/bpb.24.1320
|
[21]
|
Shalcwijk, J., Zweers, M.C., Steijlen, P.M., Dean, W.B., et al. (2007) A recessive form of the Ehlers-Danlos syndrome caused by Tenascin-X deficiency. New England Journal of Medicine, 345, 1167-1172.
doi:10.1056/NEJMoa002939
|
[22]
|
Hicklin, D.J. and Ellis L.M. (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. Journal Clinical Oncology, 23, 1011-1027.
doi:10.1200/JCO.2005.06.081
|
[23]
|
Ferrara, N. and Kerbel, R.S. (2005) Angiogenesis as a therapeutic target. Nature, 438, 967-974.
doi:10.1038/nature04483
|
[24]
|
Koch, S., Tugues, S., Li, X., Gualandi, L. and Claesson-Welsh, L. (2011) Signal transduction by vascular endothelial growth factor receptors. Biochemical Journal, 437, 169-183. doi:10.1042/BJ20110301
|
[25]
|
Dvorak, H.F., Nagy, J.A., Feng, D., Brown, L.F. and Dvorak, A.M. (1999) Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Current Topics in Microbiology and Immunology, 237, 97-132. doi:10.1007/978-3-642-59953-8_6
|
[26]
|
Zeng, H., Dvorak, H.F. and Mukhopadhyay, D. (2001) Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/ VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinasedependent pathways. Journal of Biological Chemistry, 276, 26969-26979. doi:10.1074/jbc.M103213200
|
[27]
|
Lee, S., Chen, T.T., Barber, C.L., Jordan, M.C., et al. (2007) Autocrine VEGF signaling is required for vascular homeostasis. Cell, 30, 691-703.
doi:10.1016/j.cell.2007.06.054
|
[28]
|
Smadja, D.M., Bieche, I., Helley, D., Laurendeau, I., et al. (2007) Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin 6. Journal of Cellular and Molecular Medicine, 11, 1149-1161.
doi:10.1111/j.1582-4934.2007.00090.x
|
[29]
|
Rickham, P.P. (1964) Human experimentations. Code of ethics of the World Medical Association. Declaration of Helsinki. British Medical Journal, 2, 177.
|
[30]
|
De Simone, G., Devereux, R.B., Roman, M.J., et al. (1994) Assessment of left ventricular function by the midwall fractional shortening-end-systolic stress relation in human hypertension. Journal American College of Cardiology, 23, 1444-1451.
doi:10.1016/0735-1097(94)90390-5
|
[31]
|
Devereux, R.B. and Reichek, N. (1977) Echocardiographic determination of left ventricular mass in man: Anatomic validation of method. Circulation, 5, 613-618.
doi:10.1161/01.CIR.55.4.613
|